Standard BioTools's market cap is currently ―. The company's EPS TTM is $-0.942; its P/E ratio is -2.87; Standard BioTools is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 27.67M	$ 25.12M	$ 27.02M	$ 25.65M	$ 18.78M
Gross Profit	$ 13.60M	$ 12.12M	$ 48.96M	$ 9.22M	$ 4.43M
EBIT	$ -15.61M	$ -15.46M	$ -19.59M	$ -29.09M	$ -64.09M
EBITDA	$ -12.60M	$ -12.46M	$ -16.58M	$ -25.49M	$ -60.26M
Net Income Common Stockholders	$ -17.04M	$ -16.84M	$ -20.84M	$ -29.43M	$ -63.54M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 142.30M	$ 154.54M	$ 165.78M	$ 185.17M	$ 211.21M
Total Assets	$ 355.83M	$ 371.65M	$ 390.31M	$ 414.92M	$ 441.12M
Total Debt	$ 101.39M	$ 101.98M	$ 102.67M	$ 103.10M	$ 103.57M
Net Debt	$ -40.92M	$ -52.55M	$ -63.11M	$ -82.07M	$ -107.64M
Total Liabilities	$ 157.96M	$ 157.55M	$ 160.52M	$ 477.66M	$ 478.58M
Stockholders Equity	$ -113.39M	$ -97.15M	$ -81.47M	$ -62.75M	$ -37.45M
Cash Flow	-
Free Cash Flow	$ -10.17M	$ -9.49M	$ -19.94M	$ -25.88M	$ -30.93M
Operating Cash Flow	$ -9.33M	$ -8.48M	$ -19.18M	$ -24.61M	$ -29.99M
Investing Cash Flow	$ 40.13M	$ 43.15M	$ 40.24M	$ 10.74M	$ -138.24M
Financing Cash Flow	$ -2.08M	$ -2.59M	$ -270.00K	$ -5.00K	$ 212.96M

Currency in USD

Standard BioTools Earnings and Revenue History

Income Statement >

Standard BioTools Debt to Assets

Balance Sheet >

Standard BioTools Cash Flow

Cash Flow >

Standard BioTools Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing